Efficacy of LCS compared with manual techniques

Article

Cost remains a large disadvantage to femtosecond laser cataract surgery

Femtosecond laser technology

The advancement in Femtosecond lasers has been remarkable, though debate continues about whether to become involved with the technology based on clinical efficacy and safety. The Catalys laser (Optimedica, Sunnyvale, California, USA) that our practice acquired in April 2012 has since had multiple upgrades - in particular improving power efficiency and accuracy. The most recent upgrade has reduced anterior capsulotomy time to less than 2 seconds, provided corneal incisions and dramatically reduced lens fragmentation times as well as enhancing the treatment zone. These improvements highlight that this technology has not yet reached maturity.

Another safety feature of the platform is the liquid optics interface, which causes only a small and transient rise in IOP.1 This is important for our elderly cataract patients who have significant co-morbidities such as glaucoma.

Related Videos
Ms Neeru Vallabh on a virtual call with Ophthalmology Times Europe
A screenshot of Dr Filomena Ribeiro, president of the ESCRS
Ramin Tadayoni, MD, speaks with Sheryl Stevenson
Jennifer I. Lim, MD, FARVO, FASRS, Director of Retina Service, University of Illinois at Chicago
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center
Carl D. Regillo, MD, FACS, FASRS, Chief of Retina Service, Wills Eye Hospital, Philadelphia, PA
© 2024 MJH Life Sciences

All rights reserved.